May 05, 2011 08:08 ET

Active HIV Pipeline Faces Fierce Market Competition

ROCKVILLE, MD--(Marketwire - May 5, 2011) - has announced the addition of Datamonitor's new report "R&D Trends: HIV - An active pipeline faces fierce competition in the HIV market," to their collection of Diseases & Conditions market reports. For more information, visit

Datamonitor believes that the foreseeable future of HIV treatment will be defined by earlier treatment initiation, further progress in the field of pre-exposure prophylaxis and an HIV market driven by convenience and patients' individual preferences

Monoclonal antibodies and gene treatments are among the most innovative approaches in the HIV pipeline. Progenics' Pro-140 recently entered Phase IIb clinical trials, making it the furthest advanced monoclonal antibody against HIV. In contrast, novel gene therapies deliver first promising results, but are still in very early stages of development.

The majority of pipeline drugs can be classified according to the historical HIV drug classes, but several innovative treatment approaches promise to extend future HIV treatment options.

Although there are a number of novel approaches in early-stage development for HIV, fierce competition is thinning out the late-stage pipeline. Novel treatment approaches, biomedical HIV prevention and genetic profiling could diversify an HIV market currently dominated by a one-pill once-daily regimen.

The report provides:

  • Overview of the HIV late- and early-stage pipeline and potential drug targets
  • Examination of innovative treatment approaches, such as vaccines, monoclonal antibodies and gene therapy
  • Identification of the target product profile for novel HIV treatments
  • Discussion of the future of HIV treatment and trends towards personalized HAART

For more information, visit

About is the leading provider of global market intelligence products and services. With over 300,000 research reports from more than 700 top consulting and advisory firms, offers instant online access to the world's most extensive database of expert insights on global industries, companies, products, and trends. For more information, call Veronica Franco at 240-747-3016 or visit

Contact Information

  • Contact:
    Veronica Franco
    Email Contact